2018
DOI: 10.1016/j.fertnstert.2018.07.004
|View full text |Cite
|
Sign up to set email alerts
|

The role of immunotherapy in in vitro fertilization and recurrent pregnancy loss: a systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
57
1
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 88 publications
(62 citation statements)
references
References 81 publications
1
57
1
3
Order By: Relevance
“…A Cochrane review of immunotherapy for recurrent miscarriage reporting the analysis of 20 high quality trials concluded that neither paternal cell immunization, third-party donor leukocytes, trophoblast membranes, or intravenous immunoglobulin provided any significant beneficial effect over placebo in improving the live birth rate (55). A more recent meta-analysis of the role of immunotherapy in IVF and RPL reviewed 30 studies meeting the selection criteria and led to the conclusion that the study did not show a role for immunotherapy in improving the live birth rate in women undergoing IVF treatment or in the prevention of idiopathic RPL (56). This conclusion is consistent with that of the recent Practice Committee of the ASRM guideline addressing the routine use of immunotherapies in the context of IVF (19).…”
Section: Treating Immunologic Aspects Of Recurrent Pregnancy Losssupporting
confidence: 57%
“…A Cochrane review of immunotherapy for recurrent miscarriage reporting the analysis of 20 high quality trials concluded that neither paternal cell immunization, third-party donor leukocytes, trophoblast membranes, or intravenous immunoglobulin provided any significant beneficial effect over placebo in improving the live birth rate (55). A more recent meta-analysis of the role of immunotherapy in IVF and RPL reviewed 30 studies meeting the selection criteria and led to the conclusion that the study did not show a role for immunotherapy in improving the live birth rate in women undergoing IVF treatment or in the prevention of idiopathic RPL (56). This conclusion is consistent with that of the recent Practice Committee of the ASRM guideline addressing the routine use of immunotherapies in the context of IVF (19).…”
Section: Treating Immunologic Aspects Of Recurrent Pregnancy Losssupporting
confidence: 57%
“…The intrauterine administration of corticotropin-releasing hormone (CRH)-treated autologous PBMCs was also demonstrated to improve clinical pregnancy rates of patients with repeated implantation failure [154]. Currently, the effectiveness of PBMC therapy has been positively reported [155][156][157][158].…”
Section: Topics Of Clinical Application Of Immune Therapymentioning
confidence: 99%
“…Recently, immunomodulatory drugs including steroids [117,118], intravenous immnunoglobulins [119], TNF-a antagonist [120], granulocyte colony-stimulating factor (G-CSF) agonist [121], and intravenous intralipids [122] also have been attempted for treatment of recurrent pregnancy loss and recurrent implantation failure (reviewed in [123]). The effects of these treatments are controversial [124].…”
Section: Miscarriage and Infertilitymentioning
confidence: 99%